decisionhealth Newsletters, Coder Pink Sheets - 2024 Issue 3 (March)
New code, billing method for injectable steroid
Subscribe or sign in to view the full article.
Article Overview
This article explains an April 2024 HCPCS update affecting orthopedic practices that bill for injected methylprednisolone acetate. It covers the transition from older dosing-related reporting to the updated HCPCS billing approach, notes that both physician office and facility settings are affected, and points readers to CMS update resources.
Why This Topic Matters
It helps coding and billing staff recognize that a commonly used injectable steroid now follows a different HCPCS reporting method, which can affect claim accuracy, unit reporting, and cross-checking of related billing data.
What You Will Learn
- Which federal quarterly update introduced the change
- How the update affects reporting for injected methylprednisolone acetate
- Which care settings are affected by the billing change
- How related NDC billing alignment is discussed in the article
- Where to find the CMS resources cited by the article
Who Should Read This
- Orthopedic practices
- Medical coders
- Billing staff
- Facility revenue cycle teams
- Physician office billing teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com